Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Donor Regulatory T Cells (Treg) Infusion (DTI) in Patients With Steroid-refractory Chronic Graft-versus-host Disease (GVHD)

NCT01903473 is registered in ClinicalTrials.gov with University of Liege as lead sponsor.

NCT NCT01903473
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01903473 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Donor Regulatory T Cells (Treg) Infusion (DTI) in Patients With Steroid-refractory Chronic Graft-versus-host Disease (GVHD)
Lead sponsor
University of Liege
Phase
Phase 2
Overall status
Terminated
Start date
July 31, 2013
Completion date
September 12, 2022
Enrollment
19 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

acute graft-versus-host disease, chronic graft-versus-host disease, steroid refractory graft-versus-host disease